Peer Support for Opioid Use Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist older adults on Chicago’s West Side who use opioids by reducing the stigma and barriers they face in accessing harm reduction (HR) services. The Peer Harm Reduction Support Champion Intervention will train non-substance-using friends and family members to become peer HR support champions. These champions will learn about overdose prevention and how to support their loved ones who use opioids. Participants will receive resources such as naloxone (a medication that reverses opioid overdoses) and fentanyl test strips. The trial seeks individuals who use opioids and live on the West Side of Chicago, along with their non-drug-using friends or family who wish to help them. As an unphased trial, this study offers a unique opportunity to directly contribute to community health and support loved ones.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It seems focused on harm reduction and social support, so it's unlikely that stopping medications is required.
What prior data suggests that this intervention is safe?
Research has shown that peer support services, such as the Peer Harm Reduction Support Champion Intervention, can be safely implemented. Studies have found that these programs, when integrated into a larger treatment plan, do not present major safety concerns. They emphasize education and support rather than medical treatments, making them generally manageable for participants.
Although specific studies on the side effects of this exact program are lacking, similar peer support programs have not reported major safety issues. Participants receive training and tools like naloxone and fentanyl test strips, which help reduce harm. This focus on education and community support helps lower risks and improve well-being.12345Why are researchers excited about this trial?
Researchers are excited about the Peer Harm Reduction Support Champion Intervention because it takes a unique approach by leveraging the power of social support. Unlike traditional treatments for opioid use disorder, which often focus on medical interventions like medications or counseling, this method recruits non-substance-using friends and family members to become trained champions in harm reduction. These peer champions help bridge the gap in accessing harm reduction tools and services, such as naloxone and fentanyl test strips, while also reducing stigma and increasing social support. By involving loved ones in the process, this intervention has the potential to create more sustainable and accessible support networks, ultimately aiming to reduce overdose risks and improve outcomes for individuals using opioids.
What evidence suggests that the Peer Harm Reduction Support Champion Intervention could be effective for opioid use disorder?
This trial will evaluate the effectiveness of the Peer Harm Reduction Support Champion Intervention, which trains non-substance-using friends and family members of people who use opioids to become peer support champions. Studies have shown that peer support programs can effectively assist individuals with opioid use disorder by increasing harm reduction service use and reducing overdoses. Research indicates that involving peers who have recovered from substance use can help others begin treatment and prevent future overdoses. Initial findings suggest that training friends and family to act as peer support champions can reduce stigma and increase social support. This approach not only helps people access important resources but also encourages open conversations about harm reduction.23567
Who Is on the Research Team?
Leslie D. Williams, Ph.D.
Principal Investigator
University of Illinois Chicago
Are You a Good Fit for This Trial?
This trial is for non-substance-using friends and family members of opioid users on Chicago's West side. They'll be trained as peer harm reduction support champions to help their loved ones access services and reduce stigma. Participants must recruit an opioid-using friend or family member to join the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Non-substance-using friends and family members are trained to become peer harm reduction support champions and facilitate harm reduction support for people who use opioids.
Follow-up
Participants are monitored for changes in harm reduction service access, overdose frequency, and stigma reduction.
What Are the Treatments Tested in This Trial?
Interventions
- Peer Harm Reduction Support Champion Intervention
Trial Overview
The intervention educates participants about harm reduction, provides naloxone and fentanyl test kits, and facilitates open discussions between them and their opioid-using peers. Its effectiveness in increasing service use, reducing overdoses, and decreasing stigma will be evaluated over time.
How Is the Trial Designed?
2
Treatment groups
Active Control
This intervention will recruit non-substance-using friends and family members of people who use opioids and live on the West side of Chicago, educate them on harm reduction (HR) tools and services, and train them to become peer HR support champions. They will be asked to recruit one friend or family member who uses opioids to the study, who will also be provided with an educational training on overdose risk reduction and available HR tools and services. The intervention will then facilitate a counselor-led initial conversation between peer HR support champions and their friend or family member who uses opioids, to help establish HR-related support, and will provide all participants with naloxone and fentanyl test strip kits. This intervention will not only provide another mechanism through which people who use opioids can access HR tools and services, thereby reducing logistical barriers to access and preventing overdose, but it should also reduce stigma and increase social support.
A non-equivalent comparison group will be recruited of people who use drugs (PWUD) who have recently (in the last six months) accessed harm reduction services from one of the study's community partners.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
Published Research Related to This Trial
Citations
Using Implementation Interventions and Peer Recovery ...
Effectiveness outcomes include participant engagement in MOUD (primary), probation revocation, illicit opioid use, and overdoses. Other aims include identifying ...
Peer Support for Opioid Use Disorder · Info for Participants
The intervention's efficacy will be evaluated for a) increasing uptake/use of HR services, b) decreasing overdose frequency, and c) decreasing stigma and other ...
Emergency Department Peer Support Program and Patient ...
In this cohort study of patients treated for opioid overdose, OORP implementation was associated with an increase in MOUD initiation and a decrease in repeat ...
Emergency department interventions for opioid use disorder
A study of patients in Massachusetts EDs found that 5 % who survived an opioid overdose died within one year of ED discharge; 20 % of deaths were within one ...
Williams, Leslie D. | School of Public Health
This project will work with faith-based organizations and other community partners to implement and evaluate a peer harm reduction champion intervention to ...
Findings - Emergency Department Interventions for Opioid ...
Peer support services can be implemented both as part of a comprehensive program of ED-based OUD treatment that includes medication initiation and as a ...
States Should Measure Opioid Use Disorder Treatment to ...
Medication is the most effective treatment for opioid use disorder. Methadone and buprenorphine, in particular, reduce the risk of overdose, ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.